Combination-Based Treatment Method

Patent No. EP3094331 (titled "Combination-Based Treatment Method") was filed by Nektar Therapeutics on Jan 13, 2015. The application was issued on Dec 27, 2017.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
IPSEN BIOPHARM	Sep 27, 2018	PLASSERAUD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Jul 9, 2020
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Jul 9, 2020
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Jul 6, 2020
Termination of the opposition proceedings with revocation of patent
Feb 14, 2020
Advice of delivery
Feb 12, 2020
Advice of delivery
Feb 6, 2020
Acknowledgement of a document
Feb 6, 2020
Acknowledgement of a document
Feb 6, 2020
Annex to the communication - opposition
Feb 6, 2020
Decision of the Opposition Division and instruction
Feb 6, 2020
Decision revoking the European patent
Feb 6, 2020
Grounds for the decision (Annex) - opposition
Feb 6, 2020
Internal form - Opposition/addressees
Feb 6, 2020
Internal form - Opposition/addressees
Feb 6, 2020
Means of redress
Feb 6, 2020
Minutes of the oral proceedings (Opposition Division) - conclusion of the proceedings
Feb 6, 2020
Minutes of the oral proceedings (Opposition Division) - conclusion of the proceedings
Feb 6, 2020
Minutes of the oral proceedings (Opposition Division) - introduction of the parties
Feb 6, 2020
Provision of a copy of the minutes - opposition procedure
Feb 6, 2020
Scanned annex to a communication - opposition procedure
Dec 16, 2019
Information about the result of oral proceedings
Nov 27, 2019
Brief communication - Opposition proceedings
Nov 21, 2019
(Electronic) Receipt
Nov 21, 2019
Letter accompanying subsequently filed items
Nov 21, 2019
Written submission in preparation to/during oral proceedings
Oct 23, 2019
Brief communication - Opposition proceedings
Oct 23, 2019
Brief communication - Opposition proceedings
Oct 22, 2019
Communication of amended entries
Oct 21, 2019
Submission concerning representation
Oct 18, 2019
Consolidated list of cited opposition documents
Oct 16, 2019
(Electronic) Receipt
Oct 16, 2019
(Electronic) Receipt
Oct 16, 2019
Citation in opposition procedure - 020
Oct 16, 2019
Citation in opposition procedure - 021
Oct 16, 2019
Citation in opposition procedure - 022
Oct 16, 2019
Letter accompanying subsequently filed items
Oct 16, 2019
Letter accompanying subsequently filed items
Oct 16, 2019
Written submission in preparation to/during oral proceedings
Oct 16, 2019
Written submission in preparation to/during oral proceedings
Oct 15, 2019
(Electronic) Receipt
Oct 15, 2019
Letter accompanying subsequently filed items
Jun 24, 2019
Advice of delivery
Jun 21, 2019
Advice of delivery
Jun 18, 2019
Advice of delivery
Jun 17, 2019
Advice of delivery
Jun 7, 2019
Acknowledgement of a document
Jun 7, 2019
Acknowledgement of a document
Jun 7, 2019
Annex to the communication - opposition
Jun 7, 2019
Information concerning oral proceedings
Jun 7, 2019
Summons to attend oral proceedings
Jun 7, 2019
Summons to attend oral proceedings
Mar 11, 2019
Submission concerning representation
Feb 28, 2019
Brief communication - Opposition proceedings
Feb 22, 2019
(Electronic) Receipt
Feb 22, 2019
Amended claims with annotations
Feb 22, 2019
Amended claims with annotations
Feb 22, 2019
Amended claims with annotations
Feb 22, 2019
Amended claims with annotations
Feb 22, 2019
Amended claims with annotations
Feb 22, 2019
Amended claims with annotations
Feb 22, 2019
Amended claims with annotations
Feb 22, 2019
Claims
Feb 22, 2019
Claims
Feb 22, 2019
Claims
Feb 22, 2019
Claims
Feb 22, 2019
Claims
Feb 22, 2019
Claims
Feb 22, 2019
Claims
Feb 22, 2019
Letter accompanying subsequently filed items
Feb 22, 2019
Reply of the patent proprietor to the notice(s) of opposition
Oct 12, 2018
Communication of a notice of opposition and request to file observations
Oct 12, 2018
Notice of further oppositions to opponent(s)
Oct 4, 2018
Communication of a notice of opposition - first information to patent proprietor
Sep 27, 2018
(Electronic) Receipt
Sep 27, 2018
Citation in opposition procedure - 001
Sep 27, 2018
Citation in opposition procedure - 002
Sep 27, 2018
Citation in opposition procedure - 003
Sep 27, 2018
Citation in opposition procedure - 004
Sep 27, 2018
Citation in opposition procedure - 005
Sep 27, 2018
Citation in opposition procedure - 006
Sep 27, 2018
Citation in opposition procedure - 007
Sep 27, 2018
Citation in opposition procedure - 008
Sep 27, 2018
Citation in opposition procedure - 009
Sep 27, 2018
Citation in opposition procedure - 010
Sep 27, 2018
Notice of opposition
Sep 27, 2018
Notice of opposition
Jul 3, 2018
Submission concerning representation
Jan 12, 2018
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Nov 30, 2017
Decision to grant a European patent
Nov 14, 2017
(Electronic) Receipt
Nov 14, 2017
Filing of the translations of the claims
Nov 14, 2017
French translation of claims
Nov 14, 2017
German translation of the claims
Nov 14, 2017
Letter accompanying subsequently filed items
Jul 11, 2017
Bibliographic data of the European patent application
Jul 11, 2017
Communication about intention to grant a European patent
Jul 11, 2017
Intention to grant (signatures)
Jul 11, 2017
Text intended for grant (clean copy)
Jul 11, 2017
Text intended for grant (version for approval)
May 18, 2017
Examination started
Mar 30, 2017
(Electronic) Receipt
Mar 30, 2017
Letter accompanying subsequently filed items
Mar 30, 2017
Reply to Written Opinion prepared by the EPO
Oct 26, 2016
Notification on forthcoming publication of bibliographic data
Sep 28, 2016
Communication regarding comments on written opinion/amendment of application/payment of claims fee
Sep 12, 2016
Confirmation of receipt of (electronically) transmitted priority document
Sep 5, 2016
Priority document (electronically transmitted)
Sep 5, 2016
Priority document (electronically transmitted)
Aug 19, 2016
Communication to designated inventor
Aug 19, 2016
Communication to designated inventor
Aug 19, 2016
Communication to designated inventor
Aug 3, 2016
(Electronic) Receipt
Aug 3, 2016
Amended claims filed after receipt of (European) search report
Aug 3, 2016
Request for entry into the European phase
Aug 1, 2016
Copy of the international preliminary report on patentability
May 30, 2016
Information on entry into European phase
Aug 11, 2015
Priority document (electronically transmitted)
Aug 11, 2015
Priority document (electronically transmitted)
Jul 23, 2015
Copy of the international search report
Jul 23, 2015
Published international application - A1
Mar 13, 2015
Written opinion of the ISA, boxes No. I to VIII
Mar 13, 2015
Written opinion of the ISA, cover sheet
Mar 13, 2015
Written opinion of the ISA, supplemental box

EP3094331

NEKTAR THERAPEUTICS

Application Number: EP15704116A
Filing Date: Jan 13, 2015
Status: Revoked; Jul 10, 2020
Publication Date: Dec 27, 2017
External Links: Slate, Register , Google Patents

IP Verse

Combination-Based Treatment Method

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP3094331